Seeing Interventions in a Favorable Light: The Consequences of Unblinded Trials

Affiliations

Editorial

Christopher J Yarnell. Crit Care Med. 2021.

. 2021 Oct 1;49(10):1842-1844.

doi: 10.1097/CCM.0000000000005109.

¹ Mount Sinai Hospital and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.

No abstract available

Conflict of interest statement

Dr. Yarnell has disclosed that he does not have any potential conflicts of interest.

Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials: A Meta-Epidemiological Study.
Martin GL, Trioux T, Gaudry S, Tubach F, Hajage D, Dechartres A. Martin GL, et al. Crit Care Med. 2021 Oct 1;49(10):1800-1811. doi: 10.1097/CCM.0000000000005065. Crit Care Med. 2021. PMID: 33927122

1. Moher D, Hopewell S, Schulz KF, et al.: CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c869
1. Martin GL, Trioux T, Gaudry S, et al.: Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials: A Meta-Epidemiological Study. Crit Care Med. 2021; 49:1800–1811
1. Anand R, Norrie J, Bradley JM, et al.: Fool’s gold? Why blinded trials are not always best. BMJ. 2020; 368:l6228
1. Yarnell CJ, Abrams D, Baldwin MR, et al.: Clinical trials in critical care: Can a Bayesian approach enhance clinical and scientific decision making?. Lancet Respir Med. 9:207–216